Bharat Biotech inks deal with Precisa Medicamentos for supply of COVAXIN to Brazil
Bharat Biotech has informed that the supplies of Covaxin will be prioritised for the public market, through a direct procurement by the Government of Brazil.
Bharat Biotech s Covaxin was granted restricted emegency use approval in clinical trial mode on January 2.
Hyderabad-based Bharat Biotech announced on January 12 that it has signed an agreement with Precisa Medicamentos to supply its coronavirus vaccine Covaxin to Brazil.
The vaccine maker said a team from Precisa Medicamentos had visited its facility last week to discuss potential export possibilities of Covaxin. They had met Dr Krishna Ella on January 7 and 8 and were joined by Ambassador of Brazil to India André Aranha Corrêa do Lago, who “expressed his keen interest on behalf of the Government of Brazil to procure Covaxin”.
En Inde, en français dans le texte - Littérature sans frontières rfi.fr - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from rfi.fr Daily Mail and Mail on Sunday newspapers.